@article {2321, title = {Biomarker Profiles Associated with Covid-19 Mortality in East Java, Indonesia: A Tertiary Care Hospital Study}, journal = {Pharmacognosy Journal}, volume = {16}, year = {2024}, month = {June 2024}, pages = {689-694}, type = {Research Article}, chapter = {689}, abstract = {

Objective: This study aimed to compare the most useful biomarkers for predicting prognosis and response to therapy in COVID-19 patients. Material and Methods: This quantitative study involved 639 patients who were hospitalized with COVID-19 infection. Patients without any biochemical marker result; patients referred to another hospital; and peripheral oxygen levels measured using oxygen supplementation were excluded from the study. Results: There was a statistically significant difference in terms of demographics, vital signs on admission, and laboratory parameters. The risk of mortality in COVID-19 is significantly influenced by c-reactive protein (CRP) and interleukin-6 (IL-6) levels (p-value \<0.05). Conclusion: Findings revealed these biomarkers could help the future development of more personalized treatment and diagnostic approaches.

}, keywords = {Biomarker, COVID-19, Outcome}, doi = {10.5530/pj.2024.16.110}, author = {Retno Budiarti and Ediono and Muhammad Miftahussurur and Abdulloh Machin and Mochammad Wijdan Rosyich and Ayu Imamatun Nisa and Fatimatuzzahro and Nila Novia Putri and Muhammad Ja{\textquoteright}far Shodiq} } @article {1960, title = {Analysis of The Effect of Leptin, AMPK, Adiponectin, and NPY Markers on Changes in Body Weight of Childhood Epileptic Using Valproic Acid Monotherapy}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {March 2023}, pages = {150-153}, type = {Research Article}, chapter = {150}, abstract = {

Introduction: Epilepsy is a neurological disorder that occurs due to abnormal neurons in the brain and an imbalance between excitation and inhibition in the central nervous system. The first line of OAE in children is VPA (Valproate Acid). However, long-term use can cause weight gain with a frequency of 10-70\%. The underlying mechanism of weight gain in patients remains unclear. Purpose: This study aimed to analyze the relationship between levels of biomarkers AMPK, NPY, Leptin, and Adiponectin on changes in body weight in patients with epileptic seizures using VPA monotherapy. Method: This study is an observational cohort design. Data collection in April-June 2019. Inclusion criteria were children aged 2-10 years who used VPA requirement less than two years, not taking any drugs that affect body weight, not diagnose systemic lupus, nephrotic syndrome, and diabetes mellitus. Bodyweight and all biomarkers measurement on subjects who came to the clinic at the time of study and at least after one month of taking VPA. A total of 17 subjects participated in this study. Result: The results of the statistical multivariate analysis test of VPA dosage on changes in body weight and biomarker levels found that Leptin, AMPK, Adiponectin did not significantly increase in body weight (p\>0.05), but NPY significant increase in body weight (p\<0.05). Conclusion: NPY is the most potent for appetite enhancing, preferential effect on carbohydrate intake, weight regulation, energy storage, and expenditure. Increase production of NPY, there is an increase in energy intake and then increases fat storage and body weight.

}, keywords = {Adiponectin, AMPK, Childhood., Epilepsy, Leptin, NPY, Valproic acid, Weight gain}, doi = {10.5530/pj.2023.15.21}, author = {Wardah Rahmatul Islamiyah and Nasronudin and Abdulloh Machin and Iin Ernawati and Yunita Dwi Tanti and Nur Jaya and Farah Medina and Fathia Faza Rahmadanita and Paulus Sugianto} }